Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Immuno-Oncology Congress 2024

Criteria and methodologies of evaluation for novel IO

Project Optimus: Drug dose finding in immuno-oncology

Date

13 Dec 2024

Session

Criteria and methodologies of evaluation for novel IO

Topics

Immunotherapy

Tumour Site

Presenters

Stephane Champiat

Authors

S. Champiat

Author affiliations

  • The University of Texas MD Anderson Cancer Center, Houston/US

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Simpler and more relevant trials

Presenter: Teresa Amaral

Session: Criteria and methodologies of evaluation for novel IO

Resources:

Slides

Webcast

Q&A and discussion

Session: Criteria and methodologies of evaluation for novel IO

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.